Kim J, Choi J, Kang H, Ahn J, et al. Safety, Tolerability, Pharmacokinetics, and Metabolism of Telacebec (Q203) for the Treatment of Tuberculosis: a Randomized, Placebo-Controlled, Multiple Ascending Dose Phase 1B Trial. Antimicrob Agents Chemother 2022 Dec 12:e0112322. doi: 10.1128/aac.01123.
PMID: 36507677